Clinical Trial Update: Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating post-operative adjuvant concurrent chemoradiotherapy with or without nimotuzumab for head and neck squamous cell carcinoma; status unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 3 | Status: UNKNOWN